DAART for human immunodeficiency virus-infected patients: Studying subjects not at risk for nonadherence and use of untested interventions
- PMID: 20065210
- PMCID: PMC2825565
- DOI: 10.1001/archinternmed.2009.459
DAART for human immunodeficiency virus-infected patients: Studying subjects not at risk for nonadherence and use of untested interventions
Comment on
-
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.Arch Intern Med. 2009 Jul 13;169(13):1224-32. doi: 10.1001/archinternmed.2009.172. Arch Intern Med. 2009. PMID: 19597072 Free PMC article. Clinical Trial.
Similar articles
-
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.Arch Intern Med. 2009 Jul 13;169(13):1224-32. doi: 10.1001/archinternmed.2009.172. Arch Intern Med. 2009. PMID: 19597072 Free PMC article. Clinical Trial.
-
Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study.J Acquir Immune Defic Syndr. 2010 Mar;53(3):323-32. doi: 10.1097/QAI.0b013e3181c990bf. J Acquir Immune Defic Syndr. 2010. PMID: 20032785 Clinical Trial.
-
Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patients.Curr HIV/AIDS Rep. 2009 Nov;6(4):173-4. doi: 10.1007/s11904-009-0031-y. Curr HIV/AIDS Rep. 2009. PMID: 19849959 Clinical Trial. No abstract available.
-
Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients.Expert Opin Pharmacother. 2006 Apr;7(6):793-802. doi: 10.1517/14656566.7.6.793. Expert Opin Pharmacother. 2006. PMID: 16556093 Review.
-
Emtricitabine/rilpivirine/tenofovir disoproxil fumarate single-tablet regimen: a review of its use in HIV infection.Drugs. 2014 Nov;74(17):2079-95. doi: 10.1007/s40265-014-0318-1. Drugs. 2014. PMID: 25352394 Review.
Cited by
-
Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India.PLoS One. 2012;7(8):e40723. doi: 10.1371/journal.pone.0040723. Epub 2012 Aug 27. PLoS One. 2012. PMID: 22952574 Free PMC article.
-
Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.J Acquir Immune Defic Syndr. 2010 Jun;54(2):167-79. doi: 10.1097/QAI.0b013e3181d9a330. J Acquir Immune Defic Syndr. 2010. PMID: 20375848 Free PMC article.
-
Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes.Contemp Clin Trials. 2012 Mar;33(2):436-44. doi: 10.1016/j.cct.2011.11.002. Epub 2011 Nov 12. Contemp Clin Trials. 2012. PMID: 22101218 Free PMC article. Clinical Trial.
-
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Lancet. 2010 Jul 31;376(9738):367-87. doi: 10.1016/S0140-6736(10)60829-X. Lancet. 2010. PMID: 20650518 Free PMC article. Review.
References
-
- Altice FL, Friedland GH. The era of adherence to HIV therapy. Ann Intern Med. 1998;129(6):503–505. - PubMed
-
- Wohl AR, Garland WH, Valencia R, et al. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin Infect Dis. 2006;42(11):1619–1627. - PubMed
-
- Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS. 2007;21(11):1473–1477. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical